OnKure Therapeutics Inc. (OKUR)
NASDAQ · Healthcare
OnKure Therapeutics Inc. Revenue 2024–2024
OnKure Therapeutics Inc. annual/quarterly revenue history and growth rate from 2024 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- OnKure Therapeutics Inc. annual revenue for 2024 was 0.
No data available.
OnKure Therapeutics Inc. (OKUR) — Frequently Asked Questions
OnKure Therapeutics Inc. (OKUR) is a publicly traded US company. It has a market capitalization of $15M. Explore OKUR's stock price, financial statements, earnings history, margins and key ratios below.
What is OnKure Therapeutics Inc.'s market cap?
OnKure Therapeutics Inc. (OKUR) has a market capitalization of $15M.
What is the OKUR stock price?
OKUR trades at $4.33 (+3.46% on the day).
Is OKUR profitable?
In fiscal 2024, OnKure Therapeutics Inc. reported net income of -$53M.